Nationwide cervical cancer screening in Korea: data from the National Health Insurance Service Cancer Screening Program and National Cancer Screening Program, 2009–2014

Shim, Seung‐Hyuk; Kim, Hyeong-Su; Sohn, In Sook; Hwang, Han Sung; Kwon, Han Sung; Lee, Ji Young; Kim, Soo Nyung; Lee, Kun Sei; Chang, Soung-Hoon

doi:10.3802/jgo.2017.28.e63

Cited by 20 publications

(28 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Vaccine effects require more time to stop carcinogenesis [17]. In addition, the prevalence of LSIL or HSIL in this specific hospital was higher than that in most other institutions, as reported in nationwide screening results [18]. Between 2009 and 2014, the diagnostic rates of LSIL and HSIL were 1.32% and 0.62%, respectively, at our hospital.…”

Section: Discussionmentioning

confidence: 48%

Comparison of papanicolaou smear and human papillomavirus (HPV) test as cervical screening tools: can we rely on HPV test alone as a screening method? An 11-year retrospective experience at a single institution

Kang

Cho

et al. 2020

J Pathol Transl Med

View full text Add to dashboard Cite

Background:The decrease in incidence of cervical dysplasia and carcinoma has not been as dramatic as expected with the development of improved research tools and test methods. The human papillomavirus (HPV) test alone has been suggested for screening in some countries. The National Cancer Screening Project in Korea has applied Papanicolaou smears (Pap smears) as the screening method for cervical dysplasia and carcinoma. We evaluated the value of Pap smear and HPV testing as diagnostic screening tools in a single institution. Methods: Patients co-tested with HPV test and Pap smear simultaneously or within one month of each other were included in this study. Patients with only punch biopsy results were excluded because of sampling errors. A total of 999 cases were included, and the collected reports encompassed results of smear cytology, HPV subtypes, and histologic examinations. Results: Sensitivity and specificity of detecting high-grade squamous intraepithelial lesion (HSIL) and squamous cell carcinoma (SCC) were higher for Pap smears than for HPV tests (sensitivity, 97.14%; specificity, 85.58% for Pap smears; sensitivity, 88.32%; specificity, 54.92% for HPV tests). HPV tests and Pap smears did not differ greatly in detection of low-grade squamous intraepithelial lesion (85.35% for HPV test, 80.31% for Pap smears). When atypical glandular cells were noted on Pap smears, the likelihood for histologic diagnosis of adenocarcinoma following Pap smear was higher than that of high-risk HPV test results (18.8 and 1.53, respectively). Conclusions: Pap smears were more useful than HPV tests in the diagnosis of HSIL, SCC, and glandular lesions.

show abstract

Section: Discussionmentioning

confidence: 48%

Comparison of papanicolaou smear and human papillomavirus (HPV) test as cervical screening tools: can we rely on HPV test alone as a screening method? An 11-year retrospective experience at a single institution

Kang

Cho

et al. 2020

J Pathol Transl Med

View full text Add to dashboard Cite

show abstract

“…In a 2005 US survey, over 80% of women were guideline‐concordant for cervical cancer screening . In South Korea, insurance records indicated an increase from 41% to 51% uptake between 2009 and 2014 …”

Section: Discussionmentioning

confidence: 99%

Increasing risk of uterine cervical cancer among young Japanese women: Comparison of incidence trends in Japan, South Korea and Japanese‐Americans between 1985 and 2012

Utada

Chernyavskiy

Lee

et al. 2018

Intl Journal of Cancer

View full text Add to dashboard Cite

In Japan, cervical cancer incidence has increased since the late 1990s especially among young women, despite a decreasing trend in most developed countries. Here, we examined age, period and birth cohort trends in cervical cancer incidence rates from 1985 to 2012. Incidence rates were ascertained using three population-based cancer registries and analyzed using Joinpoint regression and age-period-cohort models. We compared the findings in Japan to trends among Japanese-Americans in the Surveillance, Epidemiology, and End Results Registries and among women in South Korea using the Korea Central Registry. Age-standardized incidence rates in Japan decreased by 1.7% per year (95% confidence interval − 3.3%, 0.0%) until 1997 and thereafter increased by 2.6% per year (1.1%, 4.2%). Incidence rates increased among women under age 50, were stable among women aged 50-54, and decreased or remained stable among women aged 55 and over. The age-standardized incidence rate ratio by birth cohort showed a U-shaped pattern with the lowest rates in women born in the late 1930s and 1940s. In comparison, women born before 1920 and after 1970 had about double the incidence. Increasing risk in recent birth cohorts was not evident in Japanese-American or South Korean women. The trends in Japan may be attributable to increasing prevalence of human papillomavirus (HPV) infection among young women. Screening and vaccination have been shown to be highly effective and would help reverse these trends.

show abstract

“…The screening rates of the NCSP increased from 30.8% in 2002 to 40.9% in 2012 29. The screening rates of the NHISCSP and NCSP altogether increased from 41.1% in 2009 to 51.5% in 2014 8. Cervical cancer screening rate was positively correlated with CIS incidence (p=0.03) and strongly negatively correlated with cervical cancer incidence (p=0.04) 30.…”

Section: Discussionmentioning

confidence: 92%

“…This is primarily attributable to the organised cervical cancer screening programme introduced in Korea in 1988. As mentioned above, two types of cervical cancer screening programmes currently cover almost all Korean women aged >30 years (expanded to >20 years since 2016): (1) NHISCSP and (2) NCSP 8. Both programmes mainly use the Pap test and provide complimentary biennial screening.…”

Section: Discussionmentioning

confidence: 99%

“…Currently, the Korean government operates two population-based cervical screening programmes: the National Health Insurance Service Cancer Screening Programme (NHISCSP) for National Health Insurance Service (NHIS) beneficiaries in the upper 50% income stratum, and the National Cancer Screening Programme (NCSP) for NHIS beneficiaries in the lower 50% income stratum and Medical Aid recipients. Both programmes use the Pap test as the main screening tool and provide complimentary biennial cervical cancer screening for all Korean women aged >30 years 8. Since 2016, the programmes have included women aged >20 years.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence of human papillomavirus-related diseases in the Republic of Korea: a cross-sectional study

Oh¹,

Choi²,

Han

et al. 2019

Sex Transm Infect

View full text Add to dashboard Cite

ObjectiveWe aimed to evaluate trends in the prevalence of human papillomavirus (HPV)-related diseases in the era before the introduction of organised HPV vaccination programmes in the Republic of Korea.MethodsThis cross-sectional study used National Health Insurance Service data from 2002 to 2015 and included participants who were diagnosed with the following HPV-related diseases (codes from the International Classification of Diseases, 10th Revision): genital warts (A63.0); cancer in the head and neck (C00–C10), anus (C21), vulva (C51), vagina (C52), cervix uteri (C53) and penis (C60); carcinoma in situ (CIS) of the lip/oral cavity/pharynx (D00.0), anus (D01.3), cervix (D06), vulva (D07.1), vagina (D07.2) and penis (D07.4); benign neoplasms of the larynx (D14.1); and dysplasia of the cervix (N87), vagina (N89) and vulva (N90). For each diagnosis, the fraction of cases attributable to HPV in Korea was assessed based on the percentages of diseases attributable to HPV reported in some international studies. The age-standardised prevalence was estimated using the direct population-based method.ResultsThe overall age-standardised prevalence of HPV-related diseases increased from 2002 to 2015, mainly due to increased prevalence of genital warts in men and cervical dysplasia and CIS in women. In women, genital wart prevalence increased from 2002 (24.4 per 100 000) to 2011 (57.1) and then decreased until 2015 (53.5); in men, the prevalence increased steadily from 2002 (22.9) to 2015 (109.4). The prevalence of cervical dysplasia and CIS increased (from 86.5 in 2002 to 484.5 in 2015, and from 60.3 in 2002 to 114.9 in 2015, respectively), but that of cervical cancer decreased (from 120.0 in 2002 to 106.9 in 2015).ConclusionsNon-organised HPV vaccination and organised cervical cancer screening may have contributed to the downward trend in genital wart prevalence and the upward trend in cervical abnormalities among women.

show abstract

Nationwide cervical cancer screening in Korea: data from the National Health Insurance Service Cancer Screening Program and National Cancer Screening Program, 2009–2014

Cited by 20 publications

References 33 publications

Comparison of papanicolaou smear and human papillomavirus (HPV) test as cervical screening tools: can we rely on HPV test alone as a screening method? An 11-year retrospective experience at a single institution

Comparison of papanicolaou smear and human papillomavirus (HPV) test as cervical screening tools: can we rely on HPV test alone as a screening method? An 11-year retrospective experience at a single institution

Increasing risk of uterine cervical cancer among young Japanese women: Comparison of incidence trends in Japan, South Korea and Japanese‐Americans between 1985 and 2012

Prevalence of human papillomavirus-related diseases in the Republic of Korea: a cross-sectional study

Contact Info

Product

Resources

About